Sandoz eyes $300M PBS market

By Megan Brodie 2 years ago | In Politics, Regulatory
  • 2 years ago

26 August 2024 Sandoz has registered the first challengers for Amgen’s denosumab market ruled by…

This is subscriber-only content. Please login to continue reading.